Your cart is currently empty!
PR-TRPN 100IU
HGH 191aa HGH 191aa (Somatropin, Human Growth Hormone 191 amino acids) is a recombinant form of human growth hormone identical to the native pituitary-derived hormone. Preclinical studies in cell cultures and animal models indicate that HGH 191aa binds to the GH receptor, activates the JAK-STAT pathway, stimulates IGF-1 production in the liver, and promotes anabolic…
12 in stock
HGH 191aa
HGH 191aa (Somatropin, Human Growth Hormone 191 amino acids) is a recombinant form of human growth hormone identical to the native pituitary-derived hormone. Preclinical studies in cell cultures and animal models indicate that HGH 191aa binds to the GH receptor, activates the JAK-STAT pathway, stimulates IGF-1 production in the liver, and promotes anabolic effects on protein synthesis, lipolysis, and tissue growth.[1][2]
Key Research Areas
- Growth & Anabolic Effects – In rodent and primate models of growth hormone deficiency, HGH 191aa has been shown to increase linear growth, enhance muscle mass, and promote protein accretion through IGF-1-mediated signaling.[3][4]
- Lipolysis & Metabolic Regulation – Preclinical investigations demonstrate HGH 191aa stimulates fat mobilization, reduces adiposity, and improves lipid profiles in models of obesity and metabolic syndrome.[5][6]
- Tissue Repair & Recovery Pathways – Animal studies suggest HGH 191aa supports collagen synthesis, cartilage maintenance, and wound healing in models of injury, aging, and connective tissue damage.[7][8]
Product Specifications
| CAS Number | 12629-01-5 |
| Molecular Formula | C990H1529N263O299S7 |
| Molar Mass | 22124.12 g/mol (approximate) |
| Sequence | Full 191 amino acid sequence (recombinant human somatropin): Phe-Pro-Thr-Ile-Pro-Leu-Ser-Arg-Leu-Phe-Asp-Asn-Ala-Met-Leu-Arg-Ala-His-Arg-Leu-His-Gln-Leu-Ala-Phe-Asp-Thr-Tyr-Gln-Glu-Phe-Glu-Glu-Ala-Tyr-Ile-Pro-Lys-Glu-Gln-Lys-Tyr-Ser-Phe-Leu-Gln-Asn-Pro-Gln-Thr-Ser-Leu-Cys-Phe-Ser-Glu-Ser-Ile-Pro-Thr-Pro-Ser-Asn-Arg-Glu-Glu-Thr-Gln-Gln-Lys-Ser-Asn-Leu-Glu-Leu-Leu-Arg-Ile-Ser-Leu-Leu-Leu-Ile-Gln-Ser-Trp-Leu-Glu-Pro-Val-Gln-Phe-Leu-Arg-Ser-Val-Phe-Ala-Asn-Ser-Leu-Val-Tyr-Gly-Ala-Ser-Asp-Ser-Asn-Val-Tyr-Asp-Leu-Leu-Lys-Asp-Leu-Glu-Glu-Gly-Ile-Gln-Thr-Leu-Met-Gly-Arg-Leu-Glu-Asp-Gly-Ser-Pro-Arg-Thr-Gly-Gln-Ile-Phe-Lys-Gln-Thr-Tyr-Ser-Lys-Phe-Asp-Thr-Asn-Ser-His-Asn-Asp-Asp-Ala-Leu-Leu-Lys-Asn-Tyr-Gly-Leu-Leu-Tyr-Cys-Phe-Arg-Lys-Asp-Met-Asp-Lys-Val-Glu-Thr-Phe-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| Synonyms | Somatropin, Recombinant Human Growth Hormone, rhGH, 191aa HGH |
| Purity | ≥99% (HPLC) |
| Form | Lyophilized powder |
| Storage | −20°C (long-term), 2–8°C (reconstituted) |
| Solubility | Bacteriostatic water or sterile saline for reconstitution |
References
- 1. Kopchick JJ, et al. Growth hormone receptor antagonists: discovery and potential therapeutic uses. Endocr Rev. 2000. PubMed
- 2. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev. 1991. PubMed
- 3. Clark RG, et al. Effects of recombinant human growth hormone on growth in rats. J Endocrinol. 1987. PubMed
- 4. Skottner A, et al. Growth promoting effects of recombinant human growth hormone in hypophysectomized rats. Acta Paediatr Scand Suppl. 1986. PubMed
- 5. Jorgensen JO, et al. Effects of growth hormone on body composition in adults with growth hormone deficiency. Acta Endocrinol (Copenh). 1989. PubMed
- 6. Rudman D, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990. PubMed
- 7. Velloso CP, et al. Growth hormone action in skeletal muscle. Endocr Rev. 2001. PubMed
- 8. Laron Z. Growth hormone insensitivity (Laron syndrome). Recent Prog Horm Res. 1993. PubMed





